These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 7702795)

  • 1. Pharmacodynamic activity of intravenous E-3174, an angiotensin II antagonist, in patients with essential hypertension.
    Sweet CS; Bradstreet DC; Berman RS; Jallard N; Saenz A; Weidler DJ
    Am J Hypertens; 1994 Dec; 7(12):1035-40. PubMed ID: 7702795
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hemodynamic and humoral effects of the angiotensin II antagonist losartan in essential hypertension.
    Grossman E; Peleg E; Carroll J; Shamiss A; Rosenthal T
    Am J Hypertens; 1994 Dec; 7(12):1041-4. PubMed ID: 7702796
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypotensive effect of losartan, a nonpeptide angiotensin II receptor antagonist, in essential hypertension.
    Tsunoda K; Abe K; Hagino T; Omata K; Misawa S; Imai Y; Yoshinaga K
    Am J Hypertens; 1993 Jan; 6(1):28-32. PubMed ID: 8427658
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical experience with angiotensin II receptor antagonists.
    Brunner HR; Christen Y; Munafo A; Lee RJ; Waeber B; Nussberger J
    Am J Hypertens; 1992 Dec; 5(12 Pt 2):243S-246S. PubMed ID: 1290619
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative antihypertensive effects of losartan 50 mg and losartan 50 mg titrated to 100 mg in patients with essential hypertension.
    Ikeda LS; Harm SC; Arcuri KE; Goldberg AI; Sweet CS
    Blood Press; 1997 Jan; 6(1):35-43. PubMed ID: 9116924
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomized, placebo-controlled, double-blind, parallel study of various doses of losartan potassium compared with enalapril maleate in patients with essential hypertension.
    Gradman AH; Arcuri KE; Goldberg AI; Ikeda LS; Nelson EB; Snavely DB; Sweet CS
    Hypertension; 1995 Jun; 25(6):1345-50. PubMed ID: 7768585
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Antihypertensive effect of a non-peptide angiotensin II receptor antagonist, MK954, in patients with essential hypertension].
    Hagino T; Abe K; Tsunoda K; Yoshinaga K
    Nihon Jinzo Gakkai Shi; 1992 Feb; 34(2):133-40. PubMed ID: 1588765
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Losartan and low-dose hydrochlorothiazide in patients with essential hypertension. A double-blind, placebo-controlled trial of concomitant administration compared with individual components.
    MacKay JH; Arcuri KE; Goldberg AI; Snapinn SM; Sweet CS
    Arch Intern Med; 1996 Feb; 156(3):278-85. PubMed ID: 8572837
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of angiotensin II receptor blockade with losartan on systemic blood pressure and renal and extrarenal prostaglandin synthesis in women with essential hypertension.
    Smith MC; Barrows S; Meibohm A; Shahinfar S; Simpson RL; Weigel K; Dunn MJ
    Am J Hypertens; 1995 Dec; 8(12 Pt 1):1177-83. PubMed ID: 8998251
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of losartan on a background of hydrochlorothiazide in patients with hypertension.
    Soffer BA; Wright JT; Pratt JH; Wiens B; Goldberg AI; Sweet CS
    Hypertension; 1995 Jul; 26(1):112-7. PubMed ID: 7607713
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of losartan on blood pressure, plasma renin activity, and angiotensin II in volunteers.
    Goldberg MR; Tanaka W; Barchowsky A; Bradstreet TE; McCrea J; Lo MW; McWilliams EJ; Bjornsson TD
    Hypertension; 1993 May; 21(5):704-13. PubMed ID: 8491505
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of losartan on the renin-angiotensin-aldosterone axis in essential hypertension.
    Bauer IH; Reams GP; Wu Z; Lau-Sieckman A
    J Hum Hypertens; 1995 Apr; 9(4):237-43. PubMed ID: 7595905
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A risk-benefit assessment of losartan potassium in the treatment of hypertension.
    Burrell LM
    Drug Saf; 1997 Jan; 16(1):56-65. PubMed ID: 9010643
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DuP 532, an angiotensin II receptor antagonist: first administration and comparison with losartan.
    Goldberg MR; Lo MW; Christ DD; Chiou R; Furtek CI; Amit O; Carides A; Biollaz J; Piguet V; Nussberger J; Brunner HR
    Clin Pharmacol Ther; 1997 Jan; 61(1):59-69. PubMed ID: 9024174
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Randomised, double-blind, parallel study of the anti-hypertensive efficacy and safety of losartan potassium compared with felodipine ER in elderly patients with mild to moderate hypertension.
    Chan JC; Critchley JA; Lappe JT; Raskin SJ; Snavely D; Goldberg AI; Sweet CS
    J Hum Hypertens; 1995 Sep; 9(9):765-71. PubMed ID: 8551492
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical experience with the angiotensin II receptor antagonist losartan. A preliminary report.
    Weber MA
    Am J Hypertens; 1992 Dec; 5(12 Pt 2):247S-251S. PubMed ID: 1290620
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blood pressure and endocrine effects of single doses of CS-866, a novel angiotensin II antagonist, in salt-restricted hypertensive patients.
    Püchler K; Nussberger J; Laeis P; Witte PU; Brunner HR
    J Hypertens; 1997 Dec; 15(12 Pt 2):1809-12. PubMed ID: 9488244
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and tolerability of losartan potassium and atenolol in patients with mild to moderate essential hypertension.
    Dahlöf B; Keller SE; Makris L; Goldberg AI; Sweet CS; Lim NY
    Am J Hypertens; 1995 Jun; 8(6):578-83. PubMed ID: 7662242
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antihypertensive efficacy and safety of olmesartan and ramipril in elderly patients with mild to moderate systolic and diastolic essential hypertension.
    Mallion JM; Omboni S; Barton J; Van Mieghem W; Narkiewicz K; Panzer PK; Puig JG; Stefanadis C; Zweiker R;
    Blood Press Suppl; 2011 Apr; 1():3-11. PubMed ID: 21091270
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of losartan on renal function in patients with essential hypertension.
    Fauvel JP; Velon S; Berra N; Pozet N; Madonna O; Zech P; Laville M
    J Cardiovasc Pharmacol; 1996 Aug; 28(2):259-63. PubMed ID: 8856482
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.